These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
131 related articles for article (PubMed ID: 34599435)
21. Influence of Age, Health, and Function on Cancer Screening in Older Adults with Limited Life Expectancy. Schoenborn NL; Huang J; Sheehan OC; Wolff JL; Roth DL; Boyd CM J Gen Intern Med; 2019 Jan; 34(1):110-117. PubMed ID: 30402822 [TBL] [Abstract][Full Text] [Related]
22. ASO Author Reflections: Will Breast Cancer Screening Become Personalized? Allweis TM; Hermann N Ann Surg Oncol; 2021 Aug; 28(8):4318-4319. PubMed ID: 33393021 [No Abstract] [Full Text] [Related]
23. Spatial and temporal variations of screening for breast and colorectal cancer in the United States, 2008 to 2012. Feng X; Tan X; Alenzi EO; Rai P; Chang J Medicine (Baltimore); 2016 Dec; 95(51):e5656. PubMed ID: 28002335 [TBL] [Abstract][Full Text] [Related]
24. Socioeconomic and healthcare use-related determinants of cervical, breast and colorectal cancer screening practice in the French West Indies. Menvielle G; Dugas J; Richard JB; Luce D Eur J Cancer Prev; 2018 May; 27(3):269-273. PubMed ID: 27824663 [TBL] [Abstract][Full Text] [Related]
25. Citizenship, length of stay, and screening for breast, cervical, and colorectal cancer in women, 2000-2010. Miranda PY; Yao N; Snipes SA; BeLue R; Lengerich E; Hillemeier MM Cancer Causes Control; 2017 Jun; 28(6):589-598. PubMed ID: 28364196 [TBL] [Abstract][Full Text] [Related]
26. ASO Author Reflections: Significance of Colorectal Cancer Screening Through Preoperative Total Colonoscopy for Gastric Cancer. Koseki Y; Hikage M; Terashima M; Notsu A; Furukawa K; Fujiya K; Tanizawa Y; Takada K; Imai K; Shiomi A; Bando E Ann Surg Oncol; 2024 Feb; 31(2):810-811. PubMed ID: 38044349 [No Abstract] [Full Text] [Related]
27. Exploring implications of Medicaid participation and wait times for colorectal screening on early detection efforts in Connecticut--a secret-shopper survey. Patel VB; Nahar R; Murray B; Salner AL Conn Med; 2013 Apr; 77(4):197-203. PubMed ID: 23691732 [TBL] [Abstract][Full Text] [Related]
28. [The diffusion of screening programmes in Italy, year 2010]. Zappa M; Dardanoni G; Giorgi Rossi P; Grazzini G; Naldoni C; Paci E; Pirola ME; Pizzuti R; Segnan N; Zorzi M; Federici A Epidemiol Prev; 2012; 36(6 Suppl 1):3-7. PubMed ID: 23293267 [TBL] [Abstract][Full Text] [Related]
29. ASO Author Reflections: Breast Cancer Screening in the Safety-Net: Trying to Close the Gap When the Fault Lines Go Deep. Ahmadiyeh N Ann Surg Oncol; 2020 Dec; 27(Suppl 3):684-685. PubMed ID: 32712890 [No Abstract] [Full Text] [Related]
30. ASO Author Reflections: Constructing a Transgender and Nonbinary Cohort to Analyze Breast Cancer Screening. Ascha M; Felt D; Beach LB; Kulkarni SA; Jordan SW Ann Surg Oncol; 2022 Mar; 29(3):1718-1719. PubMed ID: 34708273 [No Abstract] [Full Text] [Related]
31. Breast, colorectal, and skin cancer screening practices and family history of cancer in U.S. women. Shah M; Zhu K; Palmer RC; Jatoi I; Shriver C; Wu H J Womens Health (Larchmt); 2007 May; 16(4):526-34. PubMed ID: 17521256 [TBL] [Abstract][Full Text] [Related]
32. ASO Author Reflections: Optimizing Breast Cancer Risk Assessment and Screening Among Black Women. Crown A; Joseph KA Ann Surg Oncol; 2023 Mar; 30(3):1722-1723. PubMed ID: 36138285 [No Abstract] [Full Text] [Related]
33. The Big 3: An Updated Overview of Colorectal, Breast, and Prostate Cancers. Gordon J; Fischer-Cartlidge E; Barton-Burke M Nurs Clin North Am; 2017 Mar; 52(1):27-52. PubMed ID: 28189165 [TBL] [Abstract][Full Text] [Related]
34. Incidence of second cancer within 5 years of diagnosis of a breast, prostate or colorectal cancer: a population-based study. Cluze C; Delafosse P; Seigneurin A; Colonna M Eur J Cancer Prev; 2009 Sep; 18(5):343-8. PubMed ID: 19436213 [TBL] [Abstract][Full Text] [Related]
35. Nonbreast cancer incidence, treatment received and outcomes: Are there differences in breast screening attendees versus nonattendees? Walpole E; Dunn N; Youl P; Harden H; Furnival C; Moore J; Taylor K; Evans E; Philpot S Int J Cancer; 2020 Aug; 147(3):856-865. PubMed ID: 31808149 [TBL] [Abstract][Full Text] [Related]
36. Cancer screening participation in schizophrenic outpatients and the influence of their functional disability on the screening rate: A cross-sectional study in Japan. Fujiwara M; Inagaki M; Nakaya N; Fujimori M; Higuchi Y; Hayashibara C; So R; Kakeda K; Kodama M; Uchitomi Y; Yamada N Psychiatry Clin Neurosci; 2017 Dec; 71(12):813-825. PubMed ID: 28875514 [TBL] [Abstract][Full Text] [Related]
37. Capsule Commentary on Tosteson et al., Variation in Screening Abnormality Rates and Follow-Up of Breast, Cervical and Colorectal Cancer Screening within the PROSPR Consortium. Kolade VO; Meseeha MG J Gen Intern Med; 2016 Apr; 31(4):411. PubMed ID: 26857730 [No Abstract] [Full Text] [Related]
38. Patient Navigation for Comprehensive Cancer Screening in High-Risk Patients Using a Population-Based Health Information Technology System: A Randomized Clinical Trial. Percac-Lima S; Ashburner JM; Zai AH; Chang Y; Oo SA; Guimaraes E; Atlas SJ JAMA Intern Med; 2016 Jul; 176(7):930-7. PubMed ID: 27273602 [TBL] [Abstract][Full Text] [Related]
39. How asymptomatic are early cancer patients of five organs based on registry data in Japan. Nakabayashi N; Hirose M; Suzuki R; Suzumiya J; Igawa M Int J Clin Oncol; 2018 Oct; 23(5):999-1006. PubMed ID: 29785620 [TBL] [Abstract][Full Text] [Related]
40. A systematic review of special events to promote breast, cervical and colorectal cancer screening in the United States. Escoffery C; Rodgers KC; Kegler MC; Haardörfer R; Howard DH; Liang S; Pinsker E; Roland KB; Allen JD; Ory MG; Bastani R; Fernandez ME; Risendal BC; Byrd TL; Coronado GD BMC Public Health; 2014 Mar; 14():274. PubMed ID: 24661503 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]